Vivakor, Inc. (VIVK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on October 30, 2025, with the Offering closing on October 31, 2025. Vivakor, Inc., a Nevada corporation listed on the Nasdaq Capital Market, is an emerging growth company. The filing details a registered direct offering of equity securities.
Key Financial Metrics and Transaction Details
- Transaction Type: Registered Direct Offering.
- Securities Issued:
- 10,600,000 shares of Common Stock at $0.18 per share.
- 3,566,666 Pre-Funded Warrants at $0.179 per warrant.
- Gross Proceeds: Approximately $2.55 million.
- Use of Proceeds: Working capital and general corporate purposes.
- Transaction Costs:
- Placement Agent Cash Fee: 7% of gross proceeds.
- Non-accountable expenses: 1% of gross proceeds.
- Reimbursement of certain expenses and legal fees.
- Warrant Terms: Pre-Funded Warrants are immediately exercisable at $0.001 per share. Ownership limitations cap beneficial ownership at 4.99% (or 9.99% upon election).
Material Changes
The filing reports a material definitive agreement entered into on October 30, 2025. This transaction results in an immediate increase in the company's outstanding share count and cash liquidity. No prior comparable period financial data (revenue, profit, or margins) is provided in this specific filing.
Outlook, Risks, and Management Commentary
Management intends to utilize the net proceeds for working capital and general corporate purposes. The offering was conducted pursuant to a shelf registration statement (Form S-3) declared effective on February 10, 2023. The filing does not contain specific forward-looking guidance, risk factors, or discussion of contingencies beyond the standard terms of the securities purchase agreement.
Key Facts for Investor Verification
- Verify the exact number of shares outstanding post-closing to assess dilution impact.
- Confirm the net proceeds after deducting the 8% total placement fees and other expenses.
- Review the "shelf" registration statement (File No. 333-269178) for any outstanding commitments or restrictions.
- Monitor the exercise of Pre-Funded Warrants, which will convert to common stock at a nominal cost.
- Check subsequent filings for the actual cash balance impact and any changes in working capital strategy.